We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Credit Acceptance
CACC
$6B
| $766K | 0.01% |
5,386
-6,498
| -55% | -$885K |
|
602
DXP Enterprises
DXPE
$2.62B
| $764K | 0.01% |
8,050
-2,330
| -22% | -$234K |
|
|
AMWD
603
DELISTED
American Woodmark
AMWD
| $761K | 0.01% |
22,600
-77,362
| -77% | -$2.66M |
|
|
KEM
604
DELISTED
KEMET Corporation
KEM
| $759K | 0.01% |
130,622
+2,100
| +2% | +$12K |
|
|
SRDX
605
DELISTED
Surmodics
SRDX
| $733K | 0.01% |
32,450
-2,200
| -6% | -$53.7K |
|
606
Huntington Bancshares
HBAN
$35.1B
| $728K | 0.01% |
+73,000
| New | +$693K |
|
607
Amkor Technology
AMKR
$16.1B
| $724K | 0.01% |
+105,492
| New | +$616K |
|
|
SCMP
608
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $723K | 0.01% |
101,156
+34,456
| +52% | +$295K |
|
609
Community Trust Bancorp
CTBI
$1.38B
| $721K | 0.01% |
19,118
| – | – |
|
|
MERU
610
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
| $720K | 0.01% |
159,594
-16,000
| -9% | -$70.8K |
|
611
WD-40
WDFC
$3.1B
| $716K | 0.01% |
9,230
-4,705
| -34% | -$342K |
|
612
Graham Holdings Company
GHC
$4.97B
| $713K | 0.01% |
1,677
-2,254
| -57% | -$920K |
|
|
INSY
613
DELISTED
Insys Therapeutics, Inc.
INSY
| $702K | 0.01% |
33,900
-14,370
| -30% | -$285K |
|
614
Arq
ARQ
$86.9M
| $701K | 0.01% |
+28,550
| New | +$737K |
|
|
NXGN
615
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $701K | 0.01% |
+41,531
| New | +$753K |
|
|
PTRY
616
DELISTED
PANTRY INC (THE)
PTRY
| $695K | 0.01% |
45,288
+32,998
| +268% | +$499K |
|
617
Plexus
PLXS
$6.81B
| $690K | 0.01% |
17,210
-4,160
| -19% | -$170K |
|
|
DST
618
DELISTED
DST Systems Inc.
DST
| $682K | 0.01% |
+14,380
| New | +$670K |
|
|
IPCC
619
DELISTED
Infinity Property & Casualty C
IPCC
| $681K | 0.01% |
10,068
| – | – |
|
620
Franklin Resources
BEN
$16.9B
| $669K | 0.01% |
12,352
-408,447
| -97% | -$22M |
|
621
CVR Energy
CVI
$3.36B
| $644K | 0.01% |
+15,240
| New | +$605K |
|
622
Hain Celestial
HAIN
$47.8M
| $640K | 0.01% |
+14,000
| New | +$638K |
|
|
DFT
623
DELISTED
DuPont Fabros Technology Inc.
DFT
| $635K | 0.01% |
+26,400
| New | +$664K |
|
|
XRM
624
DELISTED
Xerium Technologies Inc (new)
XRM
| $634K | 0.01% |
+39,480
| New | +$643K |
|
625
Teledyne Technologies
TDY
$30.4B
| $633K | 0.01% |
6,500
+150
| +2% | +$14.2K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.